PLEASE NOTE : This is a development system.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Obeticholic acid - Primary biliary cholangitis
PAD Profile : Obeticholic acid - Primary biliary cholangitis Important
Keywords :
Biliary cirrhosis
Brand Names Include :
Ocalvia
Important Information :
Dose adjustment and monitoring in pre-existing moderate / severe hepatic impairment.
NHSE specialised commissioning - RSFT only.
Traffic Light Status
Status 1 of 1.
Guidelines
No guidelines returned.
Other Drugs
Other Indications
Additional Documents
No additional documents returned.
Committee Recommendations
Date
Committee Name
Narrative
08 November 2017
Not Set
This drug falls under the responsibility of NHS England Specialised Commissioning and should therefore not be prescribed in Primary Care.
Treatment should remain with the specialist (RED) hospital only drug.
GPs should ensure that patient medication records include any medicine for which prescribing remains the responsibility of secondary or tertiary care. This will ensure that GP records, which are accessed by other healthcare providers, are a true and accurate reflection of the patient’s medication.
Associated BNF Codes
01. Gastro-Intestinal System
01.09.01. Drugs affecting biliary composition and flow